Science
Mechanism of Action
Human Amniotic Fluid Cell Conditioned Media Extract (AFSC-CM) operates through paracrine signaling, releasing a rich blend of growth factors such as IGF, bFGF, EGF, TGF-β1, alongside cytokines, chemokines, collagen, and hyaluronan. These components collectively accelerate skin healing by promoting the proliferation and migration of dermal fibroblasts and epidermal keratinocytes, thereby increasing collagen synthesis in both skin layers. AFSC-CM also aids in re-epithelialization for wound repair, potentially reducing fibrotic scarring via bone morphogenetic proteins (BMPs). Its anti-inflammatory action is supported by factors like IL-1ra and IL-10, while antioxidant activity is provided by reducing reactive oxygen species and upregulating enzymes like catalase. Furthermore, it demonstrates anti-apoptotic effects and can improve photo-aging signs by inhibiting MMP-1 and boosting procollagen 1A expression.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Optimal proliferative response on Schwann cells observed at 10 µg/mL of AFSC-CM protein, under both normative and oxidative stress conditions.
- 02 Increased cell proliferation in human dermal fibroblasts (125.95 ± 4.61%) and HaCaT cells (132.72 ± 7.48%) compared to control, with improved UVA-induced damage markers (inhibited MMP-1 expression and increased procollagen 1A expression).
- 03 Significant acceleration of wound closure by topical application in a rat whole skin-excision model, utilizing 4 × 10^9 exosome particles/100 μL, leading to enhanced collagen deposition and angiogenesis.
Transparency
Dusting Analysis
The research data provides effective concentrations for in vitro and in vivo studies (e.g., µg/mL protein, exosome particles/volume), not typical cosmetic formulation percentages. Therefore, it is not possible to assess whether this ingredient is commonly 'dusted' in cosmetic formulations.
The Formula
Formulation
Stability
This extract requires precise storage conditions, with short-term stability at 2-8 °C and long-term storage necessitating -20 °C. It is typically handled in sterile conditions without antibiotics, underscoring its sensitivity to temperature and potential microbial contamination.
Safety
Safety Profile
The FDA classifies regenerative medicine products, including those derived from amniotic fluid, as drugs or biologics, requiring premarket approval for safety and efficacy. Many such products are currently marketed as unapproved therapies, leading to FDA warning letters for non-compliance with 'minimal manipulation' or 'homologous use' criteria, and significant deviations from current good manufacturing practices (cGMP). These deviations include failures in process validation, lack of data for expiration dates, and inadequate complaint documentation.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While research indicates potential benefits for skin regeneration and anti-aging, the FDA's classification as an unapproved drug/biologic and associated significant safety and manufacturing concerns, alongside an 'Incidecoder: worst' rating, lead Moumoujus to strongly advise against its use in precision skincare.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources